Melanocortin 4 receptor activates ERK-cFos pathway to increase brain-derived neurotrophic factor expression in rat astrocytes and hypothalamus

Molecular and Cellular Endocrinology

Volumn 411, Issue , 2015, Pages 28-37

  Ramirez D ^a   Saba, J ^a   Carniglia, L ^a   Durand, D ^a   Lasaga, M ^a   Caruso, C ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Astrocytes; BDNF; CFos; ERK; Hypothalamus; MC4R

Indexed keywords

ALPHA INTERMEDIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP; MELANOCORTIN 4 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C FOS; PROTEIN TYROSINE KINASE; S6 KINASE; STRESS ACTIVATED PROTEIN KINASE; MSH, 4-NLE-7-PHE-ALPHA-;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME SUBSTRATE; HYPOTHALAMUS; IN VIVO STUDY; INTRACELLULAR SIGNALING; MALE; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RAT; UPREGULATION; ANALOGS AND DERIVATIVES; ANIMAL; CELL CULTURE; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; WISTAR RAT;

ALPHA-MSH; ANIMALS; ASTROCYTES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELLS, CULTURED; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HYPOTHALAMUS; MALE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, WISTAR; RECEPTOR, MELANOCORTIN, TYPE 4; SIGNAL TRANSDUCTION;

EID: 84930181415     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2015.04.008     Document Type: Article

References (55)

1. Bariohay B., et al. Brain-derived neurotrophic factor/tropomyosin-related kinase receptor type B signaling is a downstream effector of the brainstem melanocortin system in food intake control. Endocrinology 2009, 150:2646-2653.
2. Begriche K., et al. Melanocortin-3 receptors are involved in adaptation to restricted feeding. Genes Brain Behav 2012, 11:291-302.
3. Breit A., et al. Alternative G protein coupling and biased agonism: new insights into melanocortin-4 receptor signalling. Mol. Cell. Endocrinol 2011, 331:232-240.
4. Caruso C., et al. Alpha-melanocyte-stimulating hormone through melanocortin-4 receptor inhibits nitric oxide synthase and cyclooxygenase expression in the hypothalamus of male rats. Neuroendocrinology 2004, 79:278-286.
5. Caruso C., et al. Activation of melanocortin 4 receptors reduces the inflammatory response and prevents apoptosis induced by lipopolysaccharide and interferon-gamma in astrocytes. Endocrinology 2007, 148:4918-4926.
6. Caruso C., et al. Alpha-melanocyte-stimulating hormone modulates lipopolysaccharide plus interferon-gamma-induced tumor necrosis factor-alpha expression but not tumor necrosis factor-alpha receptor expression in cultured hypothalamic neurons. J. Neuroimmunol 2010, 227:52-59.
7. Caruso C., et al. Melanocortin 4 receptor activation induces brain-derived neurotrophic factor expression in rat astrocytes through cyclic AMP-protein kinase A pathway. Mol. Cell. Endocrinol 2012, 348:47-54.
8. Caruso C., et al. Melanocortins: anti-inflammatory and neuroprotective peptides. Neurodegeneration 2012, 93-120. Intech, Croatia. L.M.M.A.S. Loh (Ed.).
9. Caruso C., et al. Astrocytes: new targets of melanocortin 4 receptor actions. J. Mol. Endocrinol 2013, 51:R33-R50.
10. Caruso V., et al. Synaptic changes induced by melanocortin signalling. Nat. Rev. Neurosci 2014, 15:98-110.
11. Catania A. Neuroprotective actions of melanocortins: a therapeutic opportunity. Trends Neurosci 2008, 31:353-360.
12. Chai B., et al. Melanocortin-4 receptor-mediated inhibition of apoptosis in immortalized hypothalamic neurons via mitogen-activated protein kinase. Peptides 2006, 27:2846-2857.
13. Chai B., et al. Melanocortin-4 receptor activation inhibits c-Jun N-terminal kinase activity and promotes insulin signaling. Peptides 2009, 30:1098-1104.
14. Chen A.S., et al. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet 2000, 26:97-102.
15. Chu H., et al. Melanocortin 4 receptor induces hyperalgesia and allodynia after chronic constriction injury by activation of p38 MAPK in DRG. Int. J. Neurosci 2012, 122:74-81.
16. Czyzyk T.A., et al. Disruption of the RIIbeta subunit of PKA reverses the obesity syndrome of Agouti lethal yellow mice. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:276-281.
17. Damm E., et al. Melanocortin-induced PKA activation inhibits AMPK activity via ERK-1/2 and LKB-1 in hypothalamic GT1-7 cells. Mol. Endocrinol 2012, 26:643-654.
18. Daniels D., et al. Melanocortin receptor signaling through mitogen-activated protein kinase in vitro and in rat hypothalamus. Brain Res 2003, 986:1-11.
19. Durand D., et al. Reduced cAMP, Akt activation and p65-c-Rel dimerization: mechanisms involved in the protective effects of mGluR3 agonists in cultured astrocytes. PLoS ONE 2011, 6:e22235.
20. Fomina-Yadlin D., et al. Small-molecule inducers of insulin expression in pancreatic alpha-cells. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:15099-15104.
21. Giuliani D., et al. Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia. Endocrinology 2006, 147:1126-1135.
22. Giuliani D., et al. Melanocortins protect against progression of Alzheimer's disease in triple-transgenic mice by targeting multiple pathophysiological pathways. Neurobiol. Aging 2014, 35:537-547.
23. Godeny M.D., Sayeski P.P. ERK1/2 regulates ANG II-dependent cell proliferation via cytoplasmic activation of RSK2 and nuclear activation of elk1. Am. J. Physiol. Cell Physiol 2006, 291:C1308-C1317.
24. Gonzalez P., et al. Molecular mechanisms involved in interleukin 1-beta (IL-1beta)-induced memory impairment. Modulation by alpha-melanocyte-stimulating hormone (alpha-MSH). Brain Behav. Immun 2013, 34:141-150.
25. Gonzalez P.V., et al. Memory impairment induced by IL-1beta is reversed by alpha-MSH through central melanocortin-4 receptors. Brain Behav. Immun 2009, 23:817-822.
26. Herraiz C., et al. Signaling from the human melanocortin 1 receptor to ERK1 and ERK2 mitogen-activated protein kinases involves transactivation of cKIT. Mol. Endocrinol 2011, 25:138-156.
27. Huszar D., et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 1997, 88:131-141.
28. Lewin G.R., Barde Y.A. Physiology of the neurotrophins. Annu. Rev. Neurosci 1996, 19:289-317.
29. Liebmann C. Regulation of MAP kinase activity by peptide receptor signalling pathway: paradigms of multiplicity. Cell. Signal 2001, 13:777-785.
30. Luttrell L.M., et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science 1999, 283:655-661.
31. Ma Y.C., et al. Src tyrosine kinase is a novel direct effector of G proteins. Cell 2000, 102:635-646.
32. Machado I., et al. Alpha-melanocyte-stimulating hormone (alpha-MSH) reverses impairment of memory reconsolidation induced by interleukin-1 beta (IL-1 beta) hippocampal infusions. Peptides 2010, 31:2141-2144.
33. Marsh D.J., et al. Response of melanocortin-4 receptor-deficient mice to anorectic and orexigenic peptides. Nat. Genet 1999, 21:119-122.
34. McMinn J.E., et al. Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression. Am. J. Physiol. Regul. Integr. Comp. Physiol 2000, 279:R695-R703.
35. Montiel M., de la Blanca E.P., Jimenez E. P2Y receptors activate MAPK/ERK through a pathway involving PI3K/PDK1/PKC-zeta in human vein endothelial cells. Cell. Physiol. Biochem 2006, 18:123-134.
36. Najafov A., et al. Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1. Biochem. J. 2011, 433:357-369.
37. Paxinos G., Watson C. The Rat Brain in Stereostaxic Coordinates 1997, Academic Press, United States of America.
38. Perez-Cadahia B., Drobic B., Davie J.R. Activation and function of immediate-early genes in the nervous system. Biochem. Cell Biol 2011, 89:61-73.
39. Rodrigues A.R., et al. Melanocortin 5 receptor activates ERK1/2 through a PI3K-regulated signaling mechanism. Mol. Cell. Endocrinol 2009, 303:74-81.
40. Rodrigues A.R., Almeida H., Gouveia A.M. Melanocortin 5 receptor signaling and internalization: role of MAPK/ERK pathway and beta-arrestins 1/2. Mol. Cell. Endocrinol 2012, 361:69-79.
41. Romeo Y., Zhang X., Roux P.P. Regulation and function of the RSK family of protein kinases. Biochem. J. 2012, 441:553-569.
42. Sarkar S., Legradi G., Lechan R.M. Intracerebroventricular administration of alpha-melanocyte stimulating hormone increases phosphorylation of CREB in TRH- and CRH-producing neurons of the hypothalamic paraventricular nucleus. Brain Res 2002, 945:50-59.
43. Selkirk J.V., et al. Identification of differential melanocortin 4 receptor agonist profiles at natively expressed receptors in rat cortical astrocytes and recombinantly expressed receptors in human embryonic kidney cells. Neuropharmacology 2007, 52:459-466.
44. Singru P.S., et al. Refeeding-activated glutamatergic neurons in the hypothalamic paraventricular nucleus (PVN) mediate effects of melanocortin signaling in the nucleus tractus solitarius (NTS). Endocrinology 2012, 153:3804-3814.
45. Sinha P.S., Schioth H.B., Tatro J.B. Roles of the melanocortin-4 receptor in antipyretic and hyperthermic actions of centrally administered alpha-MSH. Brain Res 2004, 1001:150-158.
46. Sutton G.M., et al. Melanocortinergic modulation of cholecystokinin-induced suppression of feeding through extracellular signal-regulated kinase signaling in rat solitary nucleus. Endocrinology 2005, 146:3739-3747.
47. Tao Y.X. The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr. Rev 2010, 31:506-543.
48. Vaishnav D., et al. SP600125, an inhibitor of c-jun N-terminal kinase, activates CREB by a p38 MAPK-mediated pathway. Biochem. Biophys. Res. Commun 2003, 307:855-860.
49. Vongs A., Lynn N.M., Rosenblum C.I. Activation of MAP kinase by MC4-R through PI3 kinase. Regul. Pept 2004, 120:113-118.
50. Wang Y., Prywes R. Activation of the c-fos enhancer by the erk MAP kinase pathway through two sequence elements: the c-fos AP-1 and p62TCF sites. Oncogene 2000, 19:1379-1385.
51. Xu B., et al. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat. Neurosci 2003, 6:736-742.
52. Yeatman T.J. A renaissance for SRC. Nat. Rev. Cancer 2004, 4:470-480.
53. Zhang J., et al. c-fos regulates neuronal excitability and survival. Nat. Genet 2002, 30:416-420.
54. Zhang Y., et al. RANTES-mediated chemokine transcription in astrocytes involves activation and translocation of p90 ribosomal S6 protein kinase (RSK). J. Biol. Chem 2002, 277:19042-19048.
55. Zhu J., et al. From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors. Cancer Res 2004, 64:4309-4318.